Wall Street Analysts Think Biodesix (BDSX) Could Surge 31.91%: Read This Before Placing a BetZacks Investment Research • 08/10/26
BIAF vs. BDSX: Which Cancer Diagnostics Stock Is the Better Buy Now?Zacks Investment Research • 07/24/26
Biodesix (BDSX) Surges 10.5%: Is This an Indication of Further Gains?Zacks Investment Research • 06/19/26
3 Medical Service Industry Stocks Thriving Amid Workforce ChallengesZacks Investment Research • 06/08/26
Wall Street Analysts Believe Biodesix (BDSX) Could Rally 104.29%: Here's is How to TradeZacks Investment Research • 05/25/26
Biodesix Announces ATS 2026 Presentations Providing Real-World Clinical Evidence and Healthcare System Economic Value for Nodify Lung® Testing StrategyGlobeNewsWire • 05/11/26
Does Biodesix (BDSX) Have the Potential to Rally 103.33% as Wall Street Analysts Expect?Zacks Investment Research • 05/07/26
Biodesix Announces AACR 2026 Posters and Presentations, Highlighting Novel Diagnostic Test Discovery & Pipeline DevelopmentGlobeNewsWire • 04/06/26
Biodesix Announces the Largest Lung Nodule Biomarker Clinical Validation Study Ever Published Supporting Earlier Lung Cancer DiagnosisGlobeNewsWire • 03/20/26
Wall Street Analysts See an 86.45% Upside in Biodesix (BDSX): Can the Stock Really Move This High?Zacks Investment Research • 03/19/26
Biodesix, Inc. (BDSX) Presents at Barclays 28th Annual Global Healthcare Conference TranscriptSeeking Alpha • 03/11/26
Wall Street Analysts Think Biodesix (BDSX) Could Surge 111.62%: Read This Before Placing a BetZacks Investment Research • 03/03/26